RxDoctor Payments Data

Lindsay Choate

Physician Assistant · Jacksonville, FLNPI 1760851521

Payments from drug & device makers

$24,282in general payments, 2019–2025

Across 1,230 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$5K
  • Novo Nordisk$2K
  • AstraZeneca$1K
  • Abbott$1K
  • Boehringer Ingelheim$1K
  • Amgen$1K
  • plus $12K from 53 others

What the payments were for

  • Consulting fees$9414%
  • Speaking & faculty fees$1,6727%
  • Travel & lodging$70%
  • Food & beverage$21,53389%
  • Education$1291%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Insulet Corporation180$4,974
Novo Nordisk163$2,417
AstraZeneca(2 entities)57$1,146
Abbott51$1,137
Boehringer Ingelheim69$1,111
Amgen(2 entities)66$1,099
Amneal Pharmaceuticals LLC62$1,053
Dexcom, Inc.46$922
Mannkind Corporation33$834
Lilly USA, LLC49$830
Sanofi-aventis U.S. LLC37$738
Bayer34$667
Xeris Pharmaceuticals, Inc.33$649
Antares Pharma, Inc.25$455
Corcept Therapeutics19$442
Medtronic18$429
IBSA Pharma Inc.22$399
Amarin Pharma, Inc.26$357
Tandem Diabetes Care, Inc.13$336
Radius Health, Inc.12$302
AbbVie19$298
Cequr Corporation2$290
Merck18$288
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC15$282
Madrigal Pharmaceuticals9$273
Novartis13$261
Currax Pharmaceuticals LLC17$227
Endo Pharmaceuticals Inc.14$208
Avvisto Therapeutics, LLC11$205
Clarus Therapeutics Inc.13$193
Vistapharm, Inc.14$141
Ascendis Pharma Endocrinology Inc7$125
Bausch Health US, LLC6$107
Zealand Pharma US, Inc.5$102
Ascensia Diabetes Care US Inc.6$102
BETA Bionics, Inc.5$101
Recordati_rare_diseases_inc.4$90
Halozyme Inc3$72
Sequel Med Tech, LLC3$71
Esperion Therapeutics, Inc.4$67
Rhythm Pharmaceuticals, Inc.2$59
Acerus Pharmaceuticals Corporation3$45
Vivus LLC3$38
Tolmar, Inc.2$38
Scynexis, Inc.2$32
Astellas Pharma US Inc1$26
Neurocrine Biosciences, Inc.1$26
OPKO Pharmaceuticals, LLC1$26
Kowa Pharmaceuticals America, Inc.2$26
Embecta Corp.1$24
Soleno Therapeutics, Inc.1$22
Evoke Pharma, Inc.1$19
Kyowa Kirin, Inc.1$18
Lifescan, Inc.1$16
Regeneron Healthcare Solutions, Inc.1$15
GSK1$14
Paratek Pharmaceuticals, Inc.1$14
BD1$13
Smith+Nephew1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,282 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide271$485,523
MounjaroTirzepatide146$169,750
JardianceEmpagliflozin104$116,923
Synjardy XrEmpagliflozin/Metformin Hcl122$114,358
ProliaDenosumab61$105,820
FarxigaDapagliflozin Propanediol103$104,435
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt75$86,282
Evenity (2 Syringes)Romosozumab-Aqqg27$76,159
KerendiaFinerenone40$54,670
TrulicityDulaglutide27$51,035
Xigduo XrDapaglifloz Propaned/Metformin43$42,208
Humulin R U-500Insulin Regular, Human14$34,376
TradjentaLinagliptin32$31,313
XyostedTestosterone Enanthate38$29,530
RybelsusSemaglutide15$26,028

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$2,417$511,551286 claims
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Glyxambi, Trijardy Xr$1,111$295,207289 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog$830$226,703197 claims
AmgenProlia, Evenity (2 Syringes)$1,099$181,97988 claims
AstraZenecaFarxiga$1,146$104,435103 claims
BayerKerendia$667$54,67040 claims
MerckJanuvia, Janumet Xr$288$31,23226 claims
Antares Pharma, Inc.Xyosted$455$29,53038 claims
Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium$1,053$8,559347 claims
AbbVieSynthroid$298$5,78869 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →